Brookemont Capital Inc. ("BKT", "Brookemont" or the "Company") (TSX
VENTURE:BKT)(PINKSHEETS:BKTPF)(FRANKFURT:BRO) wishes to announce that management
will be actively pursuing additional corporate growth drivers. The new areas
that will be investigated will potentially include, but will not be limited to,
agriculture, medical, pharmaceutical, resources and real estate. At this time no
new project has been contemplated and there is no guarantee that one will be
completed.


Conrad Clemiss, president of Brookemont states, "We are constantly looking for
projects that may increase shareholder value, and given the recent excitement
generated within specific sectors such as medical marihuana, we would be not
doing our job as if we did not look into a variety of projects that may help
build BKT's assets."


Brookemont has several ongoing projects including: a) a 100% interest in the
"Albany East" Prospect. This land is prospective for hydrothermal (vein)
graphite and directly borders Zenyatta Ventures Ltd. property that hosts its
hydrothermal graphite deposit; b) a 100-per-cent interest in the Kenagami
hydrothermal graphite prospect in Ontario; and c) an aluminous clay and rare
earth prospect in the Gaspe Bay Region of Quebec, which directly borders the
Grand-Vallee Deposit of Orbite Aluminae Inc. 


If you would like to be added the BKT email list please send an email to
brookemontinfo@gmail.com.


Neither the TSX Venture Exchange Inc. nor its Regulation Service Provider (as
that term is defined in the policies of the TSX Venture Exchange Inc.) accepts
responsibility for the adequacy or accuracy of this press release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Brookemont Capital Inc.
Conrad Clemiss
President, Director
1 604 899-9150
brookemontinfo@gmail.com
www.Brookemontcapital.com